Echocardiograms and bed placement in patients with multisystem inflammatory syndrome in children

Hafsa Lodhi,Emma Singer,Mary Claire McGlynn,Jinli Wang,Erik Hoefgen,Mythili Srinivasan,William B. Orr

DOI: https://doi.org/10.21037/tp-24-161

2024-09-02

Translational Pediatrics

Abstract:Keywords: Echocardiogram; pediatric cardiology; pediatric emergency medicine; pediatric hospital medicine

pediatrics

What problem does this paper attempt to address?

Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience

Diego Cruz Vidal,Simon Lee,Stacy P. Ardoin,Djhenne Dalmacy,Juan Chaparro,Cristin Blaney,Vilmarie Rodriguez,Amanda Sankar,Shoghik Akoghlanian,Richard Lisciandro,Matthew Washam,Roshini S. Abraham,Amy Leber,Meika Eby,Berkeley Bennett,Guliz Erdem

DOI: https://doi.org/10.1097/inf.0000000000004266

2024-02-06

Abstract:We prospectively analyzed clinical and laboratory characteristics associated with cardiac involvement and severe presentation in multisystem inflammatory syndrome in children. Of 146 patients, 66 (45.2%) had cardiac dysfunction and 26 (17.8%) had coronary artery abnormalities. Lower serum albumin levels, absolute lymphocyte and platelet counts, and elevated ferritin, fibrinogen, d-dimer and interleukin-6 levels were associated with cardiac dysfunction. Possible treatment complications were identified.

pediatrics,immunology,infectious diseases
Longitudinal Echocardiographic Follow-Up of a Pediatric Multisystem Inflammatory Syndrome Cohort

Jaikumar Govindaswamy Ramamoorthy,Anantharaj Avinash,Pediredla Karunakar,Chinmay Parale,Ramanathan Velayutham,Suresh Kumar Sukumaran,Sridhar Balaguru,Narayanan Parameswaran,Mugunthan M,Rahul Dhodapkar,Debdatta Basu,Raja Selvaraj,Santhosh Satheesh,Niranjan Biswal

DOI: https://doi.org/10.5543/tkda.2023.60940

Abstract:Objective: Significant involvement of the cardiovascular system is known in multisystem inflammatory syndrome in children (MIS-C). This study aimed to examine the recovery of affected cardiovascular parameters over a medium-term follow-up. Methods: A cohort of 69 children was studied prospectively. Assessments of left ventricular (LV) function and coronary artery abnormalities (CAA) were conducted at admission, 1.5 months, and 3 months. Coronavirus Disease 2019 (COVID-19) antibody titers were assessed at these three time points. Echocardiographic and antibody parameters (rising/decreasing) were analyzed for correlation. Outcomes were assessed using logistic regression. Results: At admission, among the 78.2% of patients who were tested, 88.9% tested positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). A quarter of the patients had pericardial effusion, and half had valvulitis. Decreased ejection fraction, global circumferential strain (GCS), and global longitudinal strain (GLS) were seen in 54.4%, 68.6%, and 35.8% of patients, respectively. CAAs were observed in 27.78% of patients. Systolic dysfunction was significantly associated with older age. During follow-up, severe LV dysfunction normalized within 6-7 weeks, while mild to moderate dysfunction reached normalcy by two weeks. Both GCS and GLS reached normalcy within a median of two weeks. Diastolic parameters recovered by six weeks. Most small and moderate coronary aneurysms resolved, but a giant aneurysm in an infant remained large even after 15 months. Trends in antibodies and ejection fraction (EF) at three months were significantly correlated. Admission EF, GLS (at 6 weeks) and deceleration time (at 3 months) were significantly associated with intensive care unit (ICU) admission. The median segmental strain of the cohort remained low in certain segments at three months. Conclusion: Smaller CAAs resolve, whereas giant CAAs persist. EF and GLS are important predictors of Pediatric Intensive Care Unit (PICU) stay. The residual impairment of median segmental strain and persistent diastolic dysfunction at three months indicate the need for long-term follow-up.
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Mary Beth F. Son,Nancy Murray,Kevin Friedman,Cameron C. Young,Margaret M. Newhams,Leora R. Feldstein,Laura L. Loftis,Keiko M. Tarquinio,Aalok R. Singh,Sabrina M. Heidemann,Vijaya L. Soma,Becky J. Riggs,Julie C. Fitzgerald,Michele Kong,Sule Doymaz,John S. Giuliano,Michael A. Keenaghan,Janet R. Hume,Charlotte V. Hobbs,Jennifer E. Schuster,Katharine N. Clouser,Mark W. Hall,Lincoln S. Smith,Steven M. Horwitz,Stephanie P. Schwartz,Katherine Irby,Tamara T. Bradford,Aline B. Maddux,Christopher J. Babbitt,Courtney M. Rowan,Gwenn E. McLaughlin,Phoebe H. Yager,Mia Maamari,Elizabeth H. Mack,Christopher L. Carroll,Vicki L. Montgomery,Natasha B. Halasa,Natalie Z. Cvijanovich,Bria M. Coates,Charles E. Rose,Jane W. Newburger,Manish M. Patel,Adrienne G. Randolph

DOI: https://doi.org/10.1056/NEJMoa2102605

2021-06-18

Abstract:In the spring of 2020, the rapid emergence of multisystem inflammatory syndrome in children (MIS-C) 1-3 — a presumed postinfectious complication of coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) — necessitated decisions regarding immunomodulatory treatment without an evidence base or an understanding of its pathophysiological characteristics. Patients with MIS-C had prominent cardiovascular involvement, including shock, echocardiographic findings of decreased function, and coronary-artery aneurysms, for which they received urgent intervention. 4 Given the similarities between MIS-C and Kawasaki's disease, a vasculitis of childhood that can cause coronary-artery aneurysms and sometimes a shock-like presentation, 5 most patients with MIS-C were treated with intravenous immune globulin (IVIG), 6 the standard treatment for Kawasaki's disease. 7 Although contemporaneous studies showed clinical and immunophenotypic differences between Kawasaki's disease and MIS-C, 8-10 findings of myocarditis in many patients with MIS-C also supported treatment with IVIG, given its use in clinical practice for viral myocarditis. 11,12 Features of cytokine storm led to the use of dexamethasone in patients with acute Covid-19, 13 and the frequent concurrent finding of a severe shock-like presentation in patients with MIS-C 14 probably encouraged the use of glucocorticoids, in varying doses. 15
Role of Percutaneous ECMO and Balloon Atrial Septostomy in Multi-System Inflammatory Syndrome in Children

Ranjit R. Philip,Claire Sentilles,Jason N. Johnson,Anthony Merlocco,Karthik Ramakrishnan,Kaitlin A. Ryan,Umar Boston,Shyam Sathanandam

DOI: https://doi.org/10.3390/jcm13082168

IF: 3.9

2024-04-10

Journal of Clinical Medicine

Abstract:Multi-system inflammatory syndrome in children (MIS-C) in the setting of COVID-19 can be associated with severe cardiopulmonary dysfunction. This clinical deterioration may sometimes necessitate veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. We describe an algorithmic approach including the role of balloon atrial septostomy in this cohort. This is the first reported series of percutaneous VA-ECMO in pediatric patients with MIS-C for better outcomes. The lessons from this approach can be replicated in other pediatric clinical conditions and adds to the armament of multiple pediatric specialties.

medicine, general & internal
Myocardial deformation in multisystem inflammatory syndrome in children: layer-specific cardiac MRI insights from a pediatric cohort

Priya, Sarv

DOI: https://doi.org/10.1007/s00247-024-06086-1

2024-11-07

Pediatric Radiology

Abstract:Multilayer strain magnetic resonance imaging (MRI) analysis offers detailed insights into myocardial mechanics and cardiac function by assessing different layers of the heart muscle, enabling a comprehensive understanding of cardiac involvement.

pediatrics,radiology, nuclear medicine & medical imaging
Atrioventricular Block in Children With Multisystem Inflammatory Syndrome

Audrey Dionne,Douglas Y. Mah,Mary Beth F. Son,Pui Y. Lee,Lauren Henderson,Annette L. Baker,Sarah D. de Ferranti,David R. Fulton,Jane W. Newburger,Kevin G. Friedman

DOI: https://doi.org/10.1542/peds.2020-009704

2020-11-01

PEDIATRICS

Abstract:BACKGROUND: Children are at risk for multisystem inflammatory syndrome in children (MIS-C) after infection with severe acute respiratory syndrome coronavirus 2. Cardiovascular complications, including ventricular dysfunction and coronary dilation, are frequent, but there are limited data on arrhythmic complications. METHODS: Retrospective cohort study of children and young adults aged ≤21 years admitted with MIS-C. Demographic characteristics, electrocardiogram (ECG) and echocardiogram findings, and hospital course were described. RESULTS: Among 25 patients admitted with MIS-C (60% male; median age 9.7 [interquartile range 2.7–15.0] years), ECG anomalies were found in 14 (56%). First-degree atrioventricular block (AVB) was seen in 5 (20%) patients a median of 6 (interquartile range 5–8) days after onset of fever and progressed to second- or third-degree AVB in 4 patients. No patient required intervention for AVB. All patients with AVB were admitted to the ICU (before onset of AVB) and had ventricular dysfunction on echocardiograms. All patients with second- or third-degree AVB had elevated brain natriuretic peptide levels, whereas the patient with first-degree AVB had a normal brain natriuretic peptide level. No patient with AVB had an elevated troponin level. QTc prolongation was seen in 7 patients (28%), and nonspecific ST segment changes were seen in 14 patients (56%). Ectopic atrial tachycardia was observed in 1 patient, and none developed ventricular arrhythmias. CONCLUSIONS: Children with MIS-C are at risk for atrioventricular conduction disease, especially those who require ICU admission and have ventricular dysfunction. ECGs should be monitored for evidence of PR prolongation. Continuous telemetry may be required in patients with evidence of first-degree AVB because of risk of progression to high-grade AVB.

pediatrics
Novel Echocardiogram Analysis of Cardiac Dysfunction is Associated with Mortality in Pediatric Sepsis

Daniel T. Cater,Brett A. Meyers,Shailee Mitra,Sayantan Bhattacharya,Roberto F. Machado,Ryan Serrano,Courtney M. Rowan,Benjamin Gaston,Pavlos Vlachos

DOI: https://doi.org/10.1097/shk.0000000000002359

2024-03-25

Shock

Abstract:Abstract Objectives The objective of our study was to semi-automatically generate echocardiogram indices in pediatric sepsis using novel algorithms and determine which indices were associated with mortality. We hypothesized that strain and diastolic indices would be most associated with mortality. Design Retrospective cohort study of children with sepsis from 2017-2022. Survivors and non-survivors were compared for echocardiogram indices. Multivariate Cox proportional hazard models were constructed for our primary outcome of in-hospital mortality. Linear regression was performed for secondary outcomes, which included multiple composite 28-day outcomes. Results Of the 54 patients in the study 9 (17%) died. Multiple echocardiogram indices of both right (RV) and left ventricles (LV) were associated with in-hospital mortality [RV GLS adjusted hazard ratio (aHR): 1.16 (1.03-1.29), p-value 0.011; RV global longitudinal early diastolic strain rate (GLSre) aHR:0.24 (0.07 to 0.75), p-value 0.014; LV GLSre aHR: 0.33 (0.11-0.97), p-value 0.044]. Impairment in GLS was associated with fewer ventilator-free days [RV GLS β-coefficient: -0.47 (-0.84 to -0.10), p-value 0.013; LV GLS β-coefficient -0.62 (-1.07 to -0.17), p-value 0.008], organ-support free days [RV GLS β-coefficient: -0.49 (-0.87 to -0.11), p-value 0.013; LV GLS β-coefficient: -0.64 (-1.10 to -0.17), p-value 0.008], and days free from ICU [RV GLS β-coefficient: -0.42 (-0.79 to -0.05), p-value 0.026; LV GLS β-coefficient:-0.58 (-1.03 to -0.13), p-value 0.012]. Systolic indices were not associated with mortality in this cohort. Conclusions Our study demonstrates the feasibility of obtaining echocardiogram indices in a semi-automatic method using our algorithms. We showed that abnormal strain is associated with worse outcomes in a cohort of children with sepsis.

hematology,surgery,peripheral vascular disease,critical care medicine
Assessment of Repeated Electrocardiogram Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19

Kahraman Yakut,Isa Ozyilmaz,Nurhayat Yakut,Esma Bekece,Berna Ceylan,Muhammet Hamza Halil Toprak,Gulhan Tunca Sahin,Ibrahim Cansaran Tanıdır,Erkut Öztürk

DOI: https://doi.org/10.5812/ijp-140887

2024-05-20

Iranian Journal of Pediatrics

Abstract:Background: Cardiac involvement, stemming from the novel multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease-2019 (COVID-19), leads to common and severe complications. Objectives: The aim of this study is to compare and evaluate repetitive electrocardiogram (ECG) results and laboratory indicators in children diagnosed with MIS-C upon their initial hospital admission. Methods: This prospective, single-center study, conducted between December 2020 and October 2022, included repeated electrocardiographic and laboratory tests. Changes in the ECG over the course of the disease were regularly recorded for three months. Results: This study included 72 patients, 25 of whom were female. Mitral regurgitation and left ventricular systolic dysfunction were observed in 25% of the patients. Statistically significant differences (P < 0.05) were detected among the serial measurements of absolute neutrophil-lymphocyte count, CRP, procalcitonin, ESR, D-dimer, troponin T, pro-BNP, ferritin, and interleukin-6. Significant differences were also observed in heart rate, PR interval, QRS duration, QT duration, Fredericia QTc, JT interval, presence of sinus tachycardia, presence of first-degree AV block, presence of wide QRS, abnormal QRS axis, abnormal T axis, long QTc, and ST-T changes (P < 0.05). Additionally, significant differences were noted in the absolute lymphocyte count, troponin levels, and ferritin levels between patients with prolonged abnormal ECG findings and those whose ECG findings were normal or had returned to normal. Furthermore, statistically significant differences were observed in absolute lymphocyte count, ferritin, and fibrinogen levels among the other four groups (P < 0.05). Conclusions: Electrocardiogram findings in patients measured serially appear to improve over time. Since patients with MIS-C may experience ECG abnormalities that could lead to arrhythmias, close monitoring and the establishment of standardized approaches are essential. Long-term ECG abnormalities were associated with a decrease in absolute lymphocyte count and elevated levels of troponin, ferritin, and fibrinogen.

pediatrics
Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis

Eman A Toraih,Mohammad H Hussein,Rami M Elshazli,Adam Kline,Ruhul Munshi,Nasrin Sultana,Sharven Taghavi,Mary Killackey,Juan Duchesne,Manal S Fawzy,Emad Kandil

DOI: https://doi.org/10.1007/s12519-021-00419-y

Abstract:Background: We aimed to systematically review the clinical and laboratory features of patients with the multisystem inflammatory syndrome in pediatrics diagnosed during the COVID-19 pandemic. Data sources: A literature search in Web of Science, PubMed, Scopus, and Science Direct was made up to June 29, 2020. Results: Analysis of 15 articles (318 COVID-19 patients) revealed that although many patients presented with the typical multisystem inflammatory syndrome in pediatrics, Kawasaki-like features as fever (82.4%), polymorphous maculopapular exanthema (63.7%), oral mucosal changes (58.1%), conjunctival injections (56.0%), edematous extremities (40.7%), and cervical lymphadenopathy (28.5%), atypical gastrointestinal (79.4%) and neurocognitive symptoms (31.8%) were also common. They had elevated serum lactic acid dehydrogenase, D-dimer, C-reactive protein, procalcitonin, interleukin-6, troponin I levels, and lymphopenia. Nearly 77.0% developed hypotension, and 68.1% went into shock, while 41.1% had acute kidney injury. Intensive care was needed in 73.7% of cases; 13.2% were intubated, and 37.9% required mechanical ventilation. Intravenous immunoglobulins and steroids were given in 87.7% and 56.9% of the patients, respectively, and anticoagulants were utilized in 67.0%. Pediatric patients were discharged after a hospital stay of 6.77 days on average (95% CI 4.93-8.6). Conclusions: Recognizing the typical and atypical presentation of the multisystem inflammatory syndrome in pediatric COVID-19 patients has important implications in identifying children at risk. Monitoring cardiac and renal decompensation and early interventions in patients with multisystem inflammatory syndrome is critical to prevent further morbidity.
The Perfect Cytokine Storm: Utilization of Lung Ultrasound During Urgent Surgery in an Infant With Multisystem Inflammatory Syndrome in Children and Hemophagocytic Lymphohistiocytosis

Michael A Waterhouse,Anrew Villion,Toni Manougian,Irim Salik

DOI: https://doi.org/10.7759/cureus.15640

2021-06-14

Cureus

Abstract:Reports of children with a temporal association to severe acute respiratory syndrome coronavirus-2 hospitalized with cardiogenic shock or Kawasaki-like disease began emerging in April 2020. In May 2020, the Centers for Disease Control and Prevention published the criteria for what came to be known as multisystem inflammatory syndrome in children, a postinfectious inflammatory immune response to coronavirus disease 2019 exposure. Hemophagocytic lymphohistiocytosis is a heterogeneous disease state associated with systemic hyperinflammation secondary to immune dysregulation. We describe the utility of perioperative lung ultrasound in an infant with both disease states.
Cardiovascular Manifestations of Multisystem Inflammatory Syndrome in Children: A Single-Center Bulgarian Study

Niya Mileva,Georgi H Vasilev,Borislav Ganev,Lyubomir Chervenkov,Hristiana Batselova,Iren Tzotcheva,Latchezar Tomov,Tsvetelina Velikova,Snezhina Lazova

DOI: https://doi.org/10.3390/medicina59122175

2023-12-14

Abstract:Background and objectives: Multisystem inflammatory syndrome in children (MIS-C) poses challenges to the healthcare system, especially with frequent heart involvement. The current retrospective observational study aims to summarize the type and degree of cardiovascular involvement in children with MISC and to find possible associations between laboratory, inflammatory, and imaging abnormalities and the predominant clinical phenotype using a cluster analysis. Material and methods: We present a retrospective observational single-center study including 51 children meeting the MIS-C criteria. Results: Fifty-three percent of subjects presented with at least one sign of cardiovascular involvement (i.e., arterial hypotension, heart failure, pericardial effusion, myocardial dysfunction, pericarditis without effusion, myocarditis, coronaritis, palpitations, and ECG abnormalities). Acute pericarditis was found in 30/41 of the children (73%) assessed using imaging: 14/30 (46.7%) with small pericardial effusion and 16/30 (53.3%) without pericardial effusion. The levels of CRP were significantly elevated in the children with pericarditis (21.6 ± 13 mg/dL vs. 13.9 ± 11 mg/dL, p = 0.035), and the serum levels of IL-6 were higher in the children with small pericardial effusion compared to those without (191 ± 53 ng/L vs. 88 ± 27 ng/L, p = 0.041). Pericarditis with detectable pericardial effusion was significantly more frequent in the female vs. male subjects, 72% vs. 30% (p = 0.007). The hierarchical clustering analysis showed two clusters: Cluster 1 includes the children without cardiovascular symptoms, and Cluster 2 generalizes the MIS-C children with mild and severe cardiovascular involvement, combining pericarditis, myocarditis, heart failure, and low blood pressure. Also, subjects from Cluster 2 displayed significantly elevated levels of fibrinogen (5.7 ± 0.3 vs. 4.6 ± 0.3, p = 0.03) and IL-6 (158 ± 36 ng/mL vs. 66 ± 22 ng/mL, p = 0.032), inflammatory markers suggestive of a cytokine storm. Conclusions: Our results confirm that children with oligosymptomatic MIS-C or those suspected of long COVID-19 should be screened for possible cardiological involvement.
Case of multisystem inflammatory syndrome in children presenting as fever and abdominal pain

Neha Mahajan,Huan Ting Chang,Rachel Leeman,Rachel Manalo,Wendy Robin Glaberson

DOI: https://doi.org/10.1136/bcr-2020-237306

2020-09-08

Abstract:This case aims to remind all providers to scrutinise for atypical presentations of multisystem inflammatory syndrome in children (MIS-C) which may mimic a more routine diagnosis. In the absence of mucocutaneous symptoms, the diagnosis of MIS-C can be missed. Given the potential for rapid deterioration of patients with MIS-C, early treatment and inpatient interventions are necessary.
A Review on the Impact of Bedside Echocardiography in Managing Critically Ill Children in the Pediatric Intensive Care Unit

Sri Sita Naga Sai Priya K Jr,Amar Taksande

DOI: https://doi.org/10.7759/cureus.69769

2024-09-20

Cureus

Abstract:Over the past three decades, a variety of non-invasive hemodynamic devices have been developed. However, none of the existing methods, such as transthoracic echocardiography, esophageal Doppler ultrasound, plethysmography, thoracic impedancemetry, or sublingual capnography, fully embody the ideal characteristics of reliability, reproducibility, rapid response, ease of use, comprehensive safety, affordability, and continuous monitoring capacity. Among these, echocardiography stands out as a particularly effective approach, meeting many of these criteria due to its widespread availability, relative ease of use, and critical role in detecting anatomical abnormalities and basic changes in myocardial function. It is frequently used in pediatric intensive care units to assess the structure and function of the heart muscle. The effectiveness of echocardiography in pediatric critical care is also constrained by the need for high-quality imaging and accurate interpretation. Currently, there is a notable lack of literature on the application of echocardiography in pediatric critical care. This study seeks to evaluate the existing scientific evidence regarding the effectiveness of echocardiography as a tool for monitoring hemodynamics in pediatric critical care settings.
Assessing pattern of the Pediatric Multisystem Inflammatory Syndrome (PMIS) in children during the COVID-19 pandemic: experience from the emergency department of tertiary care center of a low-middle-income country

Saleem Akhtar,Iqra Anis,Nirdosh Ashok Kumar,Muhammad Tayyab Ihsan,Ahmed Raheem,Surraiya Bano

DOI: https://doi.org/10.1186/s12887-024-04572-x

2024-02-05

BMC Pediatrics

Abstract:Pediatric Multisystem Inflammatory Syndrome (PMIS) is a hyperinflammatory condition affecting multiple organs in children, often resembling incomplete Kawasaki Disease during later phases of COVID-19 infection. Data on PMIS in low-middle-income countries, particularly in emergency department settings, is limited.

pediatrics
Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing

Roberta L. DeBiasi,Ashraf S. Harahsheh,Hemalatha Srinivasalu,Anita Krishnan,Matthew P. Sharron,Kavita Parikh,Karen Smith,Michael Bell,Drew Michael,Meghan Delaney,Joseph Campos,Eric Vilain,Jonathan LoTempio,Jaclyn N. Kline,Tova Ronis,Suvankar Majumdar,Eleanor Sadler,Susan R. Conway,Charles I. Berul,Sangeeta Sule,Rebeca Lahoz,Emily Ansusinha,Jay Pershad,Vanessa Bundy,Elizabeth Wells,James E. Bost,David Wessel,Children's National Hospital MIS-C Taskforce,Yasser Diab,Jessica Herstek,Sona Sehgal,Hemant Sharma,Andrea Hahn,Nada Harik,Rana Hamdy,Benjamin Hanisch,Barbara Jantausch,Adeline Koay,Bernhard Wiedermann,Alexandra Yonts,Xiaoyan Song,Jennifer Dien Bard

DOI: https://doi.org/10.1016/j.jpeds.2021.06.002

IF: 6.314

2021-10-01

The Journal of Pediatrics

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To assess demographic, clinical, and biomarker features distinguishing patients with Multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study design</h3><p>We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March-September 2020 at Children's National, a quaternary freestanding Children's Hospital in Washington DC. Of this cohort, 63 of the patients had the diagnosis of MIS-C (39 confirmed, 24 probable) and 61 were from the same cohort of admitted patients who subsequently had an alternative diagnosis (controls).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Median age and sex were similar between MIS-C and controls. Black (46%) and Latino (35%) children were overrepresented in the MIS-C cohort, with Black children at highest risk (OR 4.62, 95% CI 1.151-14.10; <em>P</em> = .007). Cardiac complications were more frequent in critically ill MIS-C (55% vs. 28%; p=0.04) including systolic myocardial dysfunction (39% vs. 3%; p=0.001), and valvular regurgitation (33% vs. 7%; p=0.01). Median cycle threshold (Ct) was 31.8 (27.95--35.1 IQR) in MIS-C cases, significantly higher (indicating lower viral load) than in primary SARS-CoV-2 infection. Cytokines siL2R, IL10, and IL-6 were higher in MIS-C compared with controls. Cytokine analysis revealed sub-phenotype differences between critically ill vs. noncritically ill (IL-2, sIL2R, IL-10, Il-6); PCR positive vs. negative (TNF-α, IL10, IL-6), and presence vs. absence of cardiac abnormalities (IL-17) Phylogenetic analysis of viral genome sequences revealed predominance of GH clade originating in Europe, with no differences comparing MIS-C with primary COVID patients. Treatment was well tolerated, and no children died.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>This study establishes a well-characterized large cohort of MIS-C treated following a standardized protocol and identifies key clinical, biomarker, cytokine, viral load, and sequencing features. Long term follow up will provide opportunity for future insights into MIS-C and its sequelae.</p>

pediatrics
Atrioventricular Conduction Abnormalities in Multisystem Inflammatory Syndrome in Children

Carlos A. Carmona,Fatma Levent,Kelvin Lee,Bhavya Trivedi

DOI: https://doi.org/10.1155/2021/6124898

2021-10-01

Case Reports in Pediatrics

Abstract:Cardiac manifestations in multisystem inflammatory syndrome in children (MIS-C) can include coronary artery aneurysms, left ventricular systolic dysfunction, and electrocardiographic disturbances. We report the clinical course of three children with MIS-C while focusing on the unique considerations for managing atrioventricular conduction abnormalities. All initially had normal electrocardiograms but developed bradycardia followed by either PR prolongation or QTc elongation. Two had mild left ventricular ejection fraction dysfunction prior to developing third-degree heart block and/or a junctional escape rhythm; one had moderate left ventricular systolic dysfunction that normalized before developing a prolonged QTc. On average, our patients presented to the hospital 4 days after onset of illness. Common presenting symptoms included fevers, abdominal pain, nausea, and vomiting. Inflammatory and coagulation factors were their highest early on, and troponin peaked the highest within the first two days; meanwhile, peak brain-natriuretic peptide occurred at hospital days 3-4. The patient’s lowest left ventricular ejection fraction occurred at days 5-6 of illness. Initial electrocardiograms were benign with PR intervals below 200 milliseconds (ms); however, collectively the length of time from initial symptom presentation till when electrocardiographic abnormalities began was approximately days 8-9. When comparing the timing of electrocardiogram changes with trends in c-reactive protein and brain-natriuretic peptide, it appeared that the PR and QTc elongation patterns occurred after the initial hyperinflammatory response. This goes in line with the proposed mechanism that such conduction abnormalities occur secondary to inflammation and edema of the conduction tissue as part of a widespread global myocardial injury process. Based on this syndrome being a hyperinflammatory response likely affecting conduction tissue, our group was treated with different regimens of intravenous immunoglobulin, steroids, anakinra, and/or tocilizumab. These medications were successful in treating third-degree heart block, prolonged QTc, and a junctional ectopic rhythm.
Multisystem inflammatory syndrome in children: getting to the heart of the matter

Athena Cavounidis,Jennifer Alderson,Max Quastel

DOI: https://doi.org/10.1038/s41577-020-0409-z

IF: 108.555

2020-07-30

Nature Reviews Immunology

Abstract:<p>Nature Reviews Immunology, Published online: 30 July 2020; <a href="https://www.nature.com/articles/s41577-020-0409-z">doi:10.1038/s41577-020-0409-z</a></p>Multisystem inflammatory syndrome in children: getting to the heart of the matter

immunology
Baseline Echocardiography and Laboratory Findings in MIS-C and Associations with Clinical Illness Severity

Matthew Beaver,Bryan Jepson,Edem Binka,Dongngan Truong,Hillary Crandall,Carol McFarland,Richard Williams,Zhining Ou,Erin Treemarcki,Devri Jensen,L. LuAnn Minich,John L. Colquitt

DOI: https://doi.org/10.1007/s00246-023-03394-5

2024-02-24

Pediatric Cardiology

Abstract:Children with COVID-associated multisystem inflammatory syndrome (MIS-C) may develop severe disease. We explored the association of admission echocardiographic and laboratory parameters with MIS-C disease severity. This retrospective, single center study of consecutive MIS-C patients (4/2020-12/2021) excluded those with preexisting cardiomyopathy, congenital heart disease, or prior cardiotoxic therapy. Our hypothesis was that worse admission echocardiographic and laboratory parameters were associated with more severe disease based on vasoactive medication use. Univariable and multivariable logistic regression models assessed the association between vasoactive medication use and baseline variables. Of 118 MIS-C patients, median age was 7.8 years (IQR 4.6, 11.8), 48% received vasoactive medication. Higher admission brain natriuretic peptide [OR 1.07 (95% CI 1.02,1.14), p = 0.019], C-reactive protein [OR 1.08 (1.03,1.14), p = 0.002], troponin [OR 1.05 (1.02,1.1), p = 0.015]; lower left ventricular ejection fraction [LVEF, OR 0.96 (0.92,1), p = 0.042], and worse left atrial reservoir strain [OR 0.96 (0.92,1), p = 0.04] were associated with vasoactive medication use. Only higher CRP [OR 1.07 (1.01, 1.11), p = 0.034] and lower LVEF [0.91 (0.84,0.98), p = 0.015] remained independently significant. Among those with normal admission LVEF (78%, 92/118), 43% received vasoactive medication and only higher BNP [OR 1.09 (1.02,1.19), p = 0.021 per 100 pg/mL] and higher CRP [OR 1.07 (1.02,1.14), p = 0.013] were associated with use of vasoactive medication. Nearly half of all children admitted for MIS-C subsequently received vasoactive medication, including those admitted with a normal LVEF. Similarly, admission strain parameters were not discriminatory. Laboratory markers of systemic inflammation and cardiac injury may better predict early MIS-C disease severity.

pediatrics,cardiac & cardiovascular systems
Imaging Evaluation of Clinical and Subclinical Myocarditis in Multisystem Inflammatory Syndrome of Children with COVID-19 Using Cardiac Magnetic Resonance: The Results and Prognosis

Afrouz Alipour,Farhad Akhavein,Feisal Rahimpour,Mohammadreza Naghibi Sistani,Behzad Alizadeh

DOI: https://doi.org/10.5812/ijradiol-138650

2024-06-19

Iranian Journal of Radiology

Abstract:Background: Coronavirus disease 2019 (COVID-19) has emerged as the most significant health crisis in recent years, leading to over 6 million deaths globally due to the disease. Objectives: Given the prevalence of multisystem inflammatory syndrome in children (MISC) following the COVID-19 pandemic, this study aims to examine the imaging findings and prognoses of clinical and subclinical myocarditis in children with MISC through cardiac magnetic resonance (CMR) imaging. Patients and Methods: This prospective cohort study carried out over eighteen months from May 2021 to November 2022, included 14 patients who underwent CMR imaging. A census of all eligible patients during the study period served as the sampling method. Inclusion criteria were patients with confirmed COVID-19 infection through serological tests, polymerase chain reaction (PCR), or recent exposure to COVID-19 patients. Exclusion criteria included patients with a history of congenital heart disease (CHD) or pulmonary disease. Additional diagnostic tests performed included blood sample tests, chest X-ray (CXR), electrocardiogram (ECG), and echocardiography. CMR imaging was conducted on patients with cardiac involvement. A diagnosis of myocardial inflammation was made if a patient met at least two of the Lake Louise Criteria. The Chi-square, Fisher's exact, and Mann-Whitney tests were used to examine the relationship between quantitative variables and treatment outcomes. Additionally, the Wilcoxon signed rank, and McNemar's tests assessed changes in echocardiography findings from admission to follow-up. A significance level of 0.05 was set. Results: Among the 14 patients studied, 8 (57.10%) were girls and 6 (42.90%) were boys. The average age was 6.03 ± 3.71 years. The median time to CMR imaging after symptom onset was 4 weeks (interquartile range (IQR): 2 - 12, range: 30). Global function assessment using left ventricular ejection fraction (LVEF) showed that 5 (35.70%), 3 (21.40%), and 6 (42.90%) patients had normal function, mild dysfunction, and significant LV dysfunction, respectively. 71.40% of patients who recovered had mild tricuspid regurgitation (TR) and no cardiomegaly. Significant differences in mean values of polymorphonuclear neutrophil (PMN) (37.71 ± 11.75 vs. 81.44 ± 13.06), lymphocytes (48.71 ± 20.08 vs. 12.51 ± 7.26), hemoglobin (Hb) (12.60 ± 1.55 vs. 10.10 ± 1.62), mean corpuscular volume (MCV) (85.90 ± 5.67 vs. 79.37 ± 5.23), erythrocyte sedimentation rate (ESR) (8.86 ± 13.60 vs. 30.29 ± 21.33), and C-reactive protein (CRP) (18.91 ± 27.25 vs. 100.57 ± 85.67) were observed between non-recovered and recovered patients, respectively (P 0.05). Conclusion: Our findings indicate that a negative COVID-19 test does not exclude an established clinical COVID-19 infection in children with MISC. The results suggest that all children with MISC and a history of COVID-19 infection should undergo assessment for myocardial fibrosis, regardless of ejection fraction (EF) as determined by Echocardiography, laboratory tests, and COVID-19 test results. Strain analysis, conducted during both the acute phase and subsequent follow-ups through CMR imaging or Echocardiography, is recommended to enhance the understanding of the prognosis.

radiology, nuclear medicine & medical imaging
Notes from the Field : Surveillance for Multisystem Inflammatory Syndrome in Children — United States, 2023

Anna R. Yousaf,Katherine N. Lindsey,Michael J. Wu,Ami B. Shah,Rebecca J. Free,Regina M. Simeone,Laura D. Zambrano,Angela P. Campbell,Steven Crook,Amy Clark,Tiffanie Fulton-Kennedy,Ashley Gent,Walaa Elbedewy,Gabrielle Williams,Amanda Hartley,Kaleb Kitchens,Gillian Richardson,Marion Deming,Cole Burkholder,Jacob Reece,Tom Haupt,Amanda Mandi,Paige D’Heilly,Ayotola Falodun,C.J. Gil,Chelsea Campbell,Kimberly Carlson,Heather D. Reid,Deepam Thomas,Haytham Safi,Jacqueline Denning,Stacy Davidson,Maya Scullin,Allison Longenberger,Kelly Blythe,Xandy Peterson Pompa,Augustina Manuzak,Spencer Cunningham,Kate Cleavinger,Jannifer Anderson,Carmen Rodriguez,Lesley Roush,Paige D'Heilly,MIS-C Surveillance Authorship Group

DOI: https://doi.org/10.15585/mmwr.mm7310a2

2024-03-15

MMWR Morbidity and Mortality Weekly Report

Abstract:This report describes changes in multisystem inflammatory syndrome cases among children since early in the COVID-19 pandemic.

public, environmental & occupational health

Echocardiograms and bed placement in patients with multisystem inflammatory syndrome in children

Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience

Longitudinal Echocardiographic Follow-Up of a Pediatric Multisystem Inflammatory Syndrome Cohort

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Role of Percutaneous ECMO and Balloon Atrial Septostomy in Multi-System Inflammatory Syndrome in Children

Myocardial deformation in multisystem inflammatory syndrome in children: layer-specific cardiac MRI insights from a pediatric cohort

Atrioventricular Block in Children With Multisystem Inflammatory Syndrome

Novel Echocardiogram Analysis of Cardiac Dysfunction is Associated with Mortality in Pediatric Sepsis

Assessment of Repeated Electrocardiogram Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19

Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis

The Perfect Cytokine Storm: Utilization of Lung Ultrasound During Urgent Surgery in an Infant With Multisystem Inflammatory Syndrome in Children and Hemophagocytic Lymphohistiocytosis

Cardiovascular Manifestations of Multisystem Inflammatory Syndrome in Children: A Single-Center Bulgarian Study

Case of multisystem inflammatory syndrome in children presenting as fever and abdominal pain

A Review on the Impact of Bedside Echocardiography in Managing Critically Ill Children in the Pediatric Intensive Care Unit

Assessing pattern of the Pediatric Multisystem Inflammatory Syndrome (PMIS) in children during the COVID-19 pandemic: experience from the emergency department of tertiary care center of a low-middle-income country

Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing

Atrioventricular Conduction Abnormalities in Multisystem Inflammatory Syndrome in Children

Multisystem inflammatory syndrome in children: getting to the heart of the matter

Baseline Echocardiography and Laboratory Findings in MIS-C and Associations with Clinical Illness Severity

Imaging Evaluation of Clinical and Subclinical Myocarditis in Multisystem Inflammatory Syndrome of Children with COVID-19 Using Cardiac Magnetic Resonance: The Results and Prognosis

Notes from the Field : Surveillance for Multisystem Inflammatory Syndrome in Children — United States, 2023